PubMed · 15643579
Cymetra.
Abstract
Soft tissue replacement using a filler as a temporary scaffold to encourage revascularization and tissue in growth is an exciting concept. Sheets of acellular human dermal matrix, called Alloderm (Lifecell Corp, Branchburg, NJ), have been shown to do just that. When implanted into a patient, tissue growth and revascularization have both been observed. The company manufactures a micronized or injectable form called Cymetra. This article reviews the manufacturing, tissue interaction, clinical applications, and anticipated clinical results.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Brian P Maloney, Brent A Murphy, Harvey P Cole. 2004. Cymetra.. https://doi.org/10.1055/s-2004-861753
Cite the original work for its findings. Save a collection to share your selection of sources.